CORDIS
Wyniki badań wspieranych przez UE

CORDIS

Polski PL
A novel Androgen Synthesis Pathway in treatment-REsistant Prostate Cancer

A novel Androgen Synthesis Pathway in treatment-REsistant Prostate Cancer

Cel

Prostate cancer (PC) is the most prevalent non-cutaneous cancer in men and leads to high morbidity and mortality. Disseminated PC is treated by hormonal treatment in order to block intratumoral activation of the androgen receptor (AR) by 5α-dihydrotestosterone (DHT). Despite this treatment, eventually all patients develop castration-resistant disease (CRPC) which is accompanied by poor prognosis. Novel androgen synthesis and receptor inhibitors improve patient survival in CRPC, demonstrating the crucial role of residual androgen presence in PC despite castration.
Besides the classic DHT synthesis pathway through testosterone, recent studies in humans have shown formation of DHT through an alternative pathway that does not require testosterone as an intermediate. Activity of this alternative androgen synthesis pathway is dependent on the presence of specific steroidogenic enzymes. Results of preliminary preclinical and clinical research show that levels of alternative pathway intermediates are increased in CRPC.
Our goal is to investigate the activity and relevance of this novel pathway during progression of PC. The contribution of the alternative pathway to DHT-initiated AR activation will be explored using previously established in vitro models and sensitive steroid detection methods. This translational study will serve to discover novel targets for inhibition of intratumoral DHT synthesis and subsequent (CR)PC growth.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Koordynator

THE UNIVERSITY OF BIRMINGHAM

Adres

Edgbaston
B15 2tt Birmingham

Zjednoczone Królestwo

Rodzaj działalności

Higher or Secondary Education Establishments

Wkład UE

€ 110 803,20

Kontakt administracyjny

Xavier Rodde (Mr.)

Informacje na temat projektu

Identyfikator umowy o grant: 629745

Status

Projekt zamknięty

  • Data rozpoczęcia

    1 Marca 2014

  • Data zakończenia

    31 Lipca 2015

Finansowanie w ramach:

FP7-PEOPLE

  • Całkowity budżet:

    € 110 803,20

  • Wkład UE

    € 110 803,20

Koordynowany przez:

THE UNIVERSITY OF BIRMINGHAM

Zjednoczone Królestwo